NNelo Trade
← Back to Market News
November 12, 2026 at 09:47 PM UTC

SUTRO BIOPHARMA, INC. reports financial results in SEC 8-K

SUTRO BIOPHARMA, INC. filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: November 12, 2026 at 09:45 PM UTC

Open official source
SUTRO BIOPHARMA, INC. reports financial results in SEC 8-K | Nelo Trade